- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/775 - Apolipopeptides
Détention brevets de la classe C07K 14/775
Brevets de cette classe: 641
Historique des publications depuis 10 ans
|
29
|
41
|
47
|
43
|
41
|
27
|
37
|
45
|
50
|
22
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20868 |
26 |
| ABIONYX Pharma SA | 51 |
16 |
| CSL Limited | 243 |
14 |
| Cornell University | 3450 |
12 |
| Lawrence Livermore National Security, LLC | 1982 |
11 |
| Children's Medical Center Corporation | 1966 |
10 |
| F. Hoffmann-La Roche AG | 7796 |
9 |
| The General Hospital Corporation | 4881 |
9 |
| University of Cincinnati | 933 |
8 |
| Theripion, Inc. | 18 |
8 |
| Toray Industries, Inc. | 7145 |
7 |
| Alnylam Pharmaceuticals, Inc. | 1183 |
7 |
| Cerenis Therapeutics Holding SA | 20 |
7 |
| Cleveland HeartLab, Inc. | 23 |
7 |
| National Cancer Center | 449 |
7 |
| Bio-trip B.V. | 15 |
7 |
| Centre National de La Recherche Scientifique | 11092 |
6 |
| Duke University | 3182 |
6 |
| Indiana University Research and Technology Corporation | 781 |
6 |
| The Jackson Laboratory | 376 |
6 |
| Autres propriétaires | 452 |